US Patent:
20210299136, Sep 30, 2021
Inventors:
- Tallahassee FL, US
Branko Stefanovic - Tallahassee FL, US
International Classification:
A61K 31/542
A61P 19/04
Abstract:
This discloses that compounds of Formula 1 may be used as antifibrotics because they inhibit type 1 collagen production. In particular, this discloses a pharmaceutical composition containing one or more compounds of Formula 1 and methods of using compounds of Formula 1 in fibrosis treatment and inhibiting type 1 collagen synthesis.